Phase II_VRP - HER2Pembrolizumab_Breast Cancer_Duke IRB Pro00100093 A Phase II Randomized Study to Evaluate the Immunologic and Antitumor Activity of Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Advanced HER2-overexpressing Breast Cancer

Project: Clinical Trial

Project Details

StatusNot started